GlassScriptPhysician profile
Shruti Dosi
NPI 1083110571
$13,022.95
in general payments reported to CMS, 2019-2025
23 companies · $618 in 2025
The $618 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,191 · 2022: $6,202 · 2023: $3,477 · 2024: $535 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,769 · Travel and Lodging: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,769.30 |
| Travel and Lodging | $860.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,057.31 | 2021-2025 | Prostep, Infinity, Prophecy |
| Arthrex, INC. | $2,993.58 | 2022-2025 | |
| Integra Lifesciences Corporation | $2,653.48 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Reel Surgical, INC. | $1,225.50 | 2022 | |
| Sanara Medtech INC. | $355.89 | 2023-2024 | Celleraterx |
| Linvatec Corporation | $276.89 | 2023 | Allograft Tissue, Colink 2, In2bones USA |
| Flower Orthopedics Coporation | $268.39 | 2022 | |
| Medshape, INC. | $235.03 | 2022 | |
| Fusion Orthopedics USA, LLC | $172.13 | 2025 | |
| Depuy Synthes Sales INC. | $143.99 | 2021-2023 | N/A, Fibulink, Na |
| Crossroads Orthopedics, LLC | $125.00 | 2022 | |
| Abbott Laboratories | $123.61 | 2021 | |
| Smith+Nephew, INC. | $76.89 | 2024 | Collagenase Santyl, Stravix, Grafix |
| Medtronic, INC. | $76.77 | 2023-2025 | Abre, Venaseal, Accurian |
| Paratek Pharmaceuticals, INC. | $73.16 | 2021-2024 | Nuzyra |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $35.47 | 2021 | |
| Nevro Corp. | $32.39 | 2023-2024 | Senza |
| Novastep INC. | $19.11 | 2022 | |
| Globus Medical, INC. | $18.95 | 2025 | Senza |
| Reprise Biomedical, INC. | $16.13 | 2025 | Miro3d |
| Averitas Pharma INC. | $15.01 | 2023 | Qutenza |
| Embody, INC. | $14.17 | 2022 | |
| Ebi, LLC | $14.10 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shruti Dosi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.